资料显示，爱旭股份成立于1996年8月，主营业务是研发、生产、销售太阳能电池和组件。 爱旭股份：预计上半年预亏1.7亿–2.8亿元 7月10日晚，爱旭股份（600732）发布2025年半年度业绩预告，公司预计上半年实现归属于母公司所有 者的净亏损1.7亿元至2.8亿元，预计实现扣除非经常性损益后的净亏损4.1亿元至5.2亿元。 所属行业：电力设备–光伏设备–光伏电池组件 长城军工：预计上半年预亏2500万–2950万元 7月10日晚，长城军工（601606）发布2025年半年度业绩预告，公司预计上半年实现归属于上市公司股 东的净亏损2500万元至2950万元，预计实现扣除非经常性损益后的净亏损3500万元至4100万元。 资料显示，长城军工成立于2000年11月，主营业务是军品业务与民品业务。 所属行业：国防军工–地面兵装Ⅱ–地面兵装Ⅲ 长源东谷：预计上半年净利润预增62.65%-88.88% 7月10日晚，长源东谷（603950）发布2025年半年度业绩预告，公司预计上半年实现归属于母公司所有 者的净利润1.55亿元至1.8亿元，同比增长62.65%-88.88%；预计实现扣除非经常性损益后的净利润1.5亿 ...

Group 1 - The major shareholder, Qichuang Tianrui Investment, plans to reduce its stake in Silin Jie by up to 2,000,100 shares, representing a maximum of 3.00% of the total share capital [1] - Qichuang Tianrui currently holds 4,799,500 shares, which is 7.20% of the total share capital, and these shares became tradable on March 14, 2023 [1] - The reduction will occur through centralized bidding and block trading, with specific limits on the number of shares that can be sold within certain time frames [1] Group 2 - Silin Jie was listed on the Sci-Tech Innovation Board on March 14, 2022, with an initial public offering of 16.67 million shares at a price of 65.65 yuan per share [2] - The total funds raised by Silin Jie amounted to 1.094 billion yuan, with a net amount of 975 million yuan after deducting issuance costs, exceeding the original plan by 418 million yuan [2] - The company intended to use the raised funds for expansion projects and operational funding, but the stock is currently trading below its IPO price [2] Group 3 - The total issuance costs for Silin Jie were 119 million yuan, with the lead underwriter, Minsheng Securities, receiving 93.02 million yuan in underwriting fees [3] - The strategic placement involved Minsheng Investment, a subsidiary of the underwriter, which acquired 66,680 shares, amounting to 43.7754 million yuan, with a lock-up period of 24 months [3]

7月9日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 2025.07. 09 【品大事】 五连板华光环能：公司生产经营活动一切正常 基本面没有发生重大变化 五连板华光环能(600475)发布股票交易风险提示公告称，近5个交易日公司股票累计换手率为 29.41%，接近30%，公司股票可能存在非理性炒作风险。截至目前，公司主要围绕环保与能源两大 领域开展设计咨询、设备制造、工程建设、运营管理、投资等一体化业务。公司生产经营活动一切正 常，内部生产经营秩序正常，基本面没有发生重大变化，主营业务结构未发生重大变化，内外部经营 环境未发生重大变化。 安德利：实控人之一王安向其女王萌转让所持BVI平安90%股权 安德利(605198)公告，公司控股股东China Pingan Investment Holdings Limited（BVI平安）近 期发生股权结构变动，实际控制人之一王安向其女王萌转让其持有的BVI平安90%的股权。此次转让 不涉及通过证券交易所的交易行为，控股股东、实际控制人及其一致行动人持有的公司股份数量、持 股比例及表决权均未发生变化。股权结构变动完成后，B ...

Group 1: Company Announcements - Huayin Power's stock has seen a significant short-term increase, with a cumulative rise of 79.82% since July 1, 2025, which is substantially higher than the industry and Shanghai Composite Index [5] - Zhongyan Chemical's subsidiary acquired natural soda mining rights for 6.80866 billion yuan [6] - Shudao Equipment has terminated the acquisition of a 65.43% stake in Keyi Gas [10] - New Link Electronics expects a net profit of 166 million to 198 million yuan for the first half of 2025, marking a turnaround from a loss of 41.2841 million yuan in the same period last year [12] Group 2: Profit Forecasts - Xian Da Co. anticipates a net profit increase of 2443.43% to 2834.73%, projecting 130 million to 150 million yuan for the first half of 2025 [2] - Shanghai Pharmaceuticals expects a net profit of 4.45 billion yuan for the first half of 2025, a 52% increase from the previous year [3] - Yonghe Co. forecasts a net profit of 255 million to 280 million yuan, representing a year-on-year increase of 126.30% to 148.49% [4] - Xiangyuan Cultural Tourism projects a net profit of 90 million to 97 million yuan, an increase of 51.44% to 63.22% [5] - Ganli Pharmaceutical expects a net profit of 600 million to 640 million yuan, a growth of 100.73% to 114.12% [6] - Jiangshan Co. anticipates a net profit of 300 million to 360 million yuan, reflecting a year-on-year increase of 75.65% to 110.78% [6] - Zhiwei Intelligent expects a net profit of 91.98 million to 112 million yuan, a growth of 62.85% to 99.06% [9] - Wanliyang forecasts a net profit of 270 million to 290 million yuan, an increase of 46.68% to 57.55% [11] - Wohua Pharmaceutical expects a net profit of 37 million to 53 million yuan, a significant increase of 233.89% to 378.27% [14] - Chenguang Biological anticipates a net profit of 202 million to 232 million yuan, a growth of 102.33% to 132.38% [15] - Muyuan Foods expects a net profit of 10.5 billion to 11 billion yuan, a staggering increase of 924.6% to 973.39% [15] - New Beiyang forecasts a net profit of 34.7 million to 38.2 million yuan, a growth of 100% to 120% [16]

Group 1: Company Performance - Northern Rare Earth expects a net profit of 900 million to 960 million yuan for the first half of 2025, representing a year-on-year increase of 1882.54% to 2014.71% [1] - Muyuan Foods anticipates a net profit of 10.5 billion to 11 billion yuan for the first half of 2025, reflecting a year-on-year growth of 924.6% to 973.39% [2] - Hongta Securities projects a net profit of 651 million to 696 million yuan for the first half of 2025, indicating a year-on-year increase of 45% to 55% [3] Group 2: Business Developments - Dazhihui clarifies that it has not engaged in businesses related to "stablecoins," "virtual asset trading," or "cross-border payments," following a significant stock price fluctuation [4] - Bluetech announces a share transfer agreement where its actual controller will change, with the Ma'anshan Municipal Government becoming the actual controller after the transfer of 18% of shares [5] Group 3: Industry Trends - Jiangsu Electric Power reports a 5.01% year-on-year increase in electricity generation for the first half of 2025 [6] - Jin'an Guoji anticipates a non-recurring net profit growth of 4700% to 6300% for the first half of 2025 [6] - New Beiyang expects a non-recurring net profit growth of 650% to 720% for the first half of 2025 [6]

证券代码：688115 证券简称：思林杰 公告编号：2025-034 广州思林杰科技股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 股东持股的基本情况 截至本公告披露日，横琴启创天瑞投资企业（有限合伙） （以下简称"启创天 瑞"）持有广州思林杰科技股份有限公司（以下简称"思林杰"或"公司"）股份 份，已于 2023 年 3 月 14 日解除限售并上市流通。 ②减持股份的方式 锁定期届满后，本人/本企业拟通过包括但不限于二级市场集中竞价交易、 大宗交易、协议转让等方式减持所持有的公司股份。 ? 减持计划的主要内容 公司于近日收到股东启创天瑞出具的《减持计划告知函》。因其自身资金需 求，启创天瑞计划通过集中竞价、大宗交易方式减持其持有的公司股份不超过 之日起 15 个交易日后的 3 个月内进行。其中，拟通过集中竞价方式减持不超过 过公司总股本的 1.00%；拟通过大宗交易方式减持不超过 1,333,400 股，即不得 超过公司总股本的 2.0 ...

证券代码：688115 证券简称：思林杰 公告编号：2025-034 广州思林杰科技股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 截至本公告披露日，横琴启创天瑞投资企业（有限合伙）（以下简称"启创天 瑞"）持有广州思林杰科技股份有限公司（以下简称"思林杰"或"公司"）股份 4,799,500 股，占公司总股本的 7.20%，股份来源于公司首次公开发行前持有的股 份，已于 2023 年 3 月 14 日解除限售并上市流通。 减持计划的主要内容 公司于近日收到股东启创天瑞出具的《减持计划告知函》。因其自身资金需 求，启创天瑞计划通过集中竞价、大宗交易方式减持其持有的公司股份不超过 2,000,100 股，减持比例不超过公司总股本的 3.00%，自本减持股份计划公告披露 之日起 15 个交易日后的 3 个月内进行。其中，拟通过集中竞价方式减持不超过 666,700 股，即不超过公司总股本的 1.00%，且任意连续 90 日减持 ...

思林杰7月9日公告，公司持股5%以上股东横琴启创天瑞投资企业(有限合伙)因自身资金需求，计划自 2025年7月31日起至2025年10月30日止，通过集中竞价和大宗交易方式减持公司股份不超过200.01万 股，即不超过公司总股本的3%。其中，通过集中竞价方式减持不超过66.67万股，通过大宗交易方式减 持不超过133.34万股。减持价格将根据减持实施时的市场价格确定。 ...

公司公告汇总 广州思林杰科技股份有限公司发布2024年年度权益分派实施公告。每股派发现金红利0.22元，不涉及差 异化分红送转。相关日期为：股权登记日2025年6月6日，除权（息）日和现金红利发放日均为2025年6 月9日。本次利润分配方案经2025年5月19日的2024年年度股东会审议通过，以方案实施前的公司总股本 66,670,000股为基数，共计派发现金红利14,667,400元。无限售条件流通股的红利委托中国结算上海分公 司派发。对于持有公司无限售条件流通股的自然人股东和证券投资基金，实际派发的现金红利为税前每 股人民币0.22元，根据持股期限计算应纳税额。对于有限售条件流通股个人股东和证券投资基金，解禁 前取得的股息红利实际税负为10%，税后每股实际派发现金红利人民币0.198元。对于持有公司有限售 条件流通股的非居民企业，按10%的税率征收企业所得税，税后每股实际派发现金红利人民币0.198 元。对于合格境外机构投资者（QFII），扣税后实际发放现金红利为每股人民币0.198元。对于持有公 司股票的香港市场投资者，税后每股实际派发现金红利人民币0.198元。对于其他机构投资者和法人股 东，公司实际 ...

Core Points - The company announced a cash dividend of RMB 0.22 per share, totaling RMB 14,667,400 for all shareholders [1][2] - The dividend distribution plan was approved at the annual shareholders' meeting on May 19, 2025 [1] - The dividend will be distributed based on the total share capital of 66,670,000 shares as of the record date [1] Dividend Distribution Details - The cash dividend will be distributed to shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, after the market closes on the record date [2] - Shareholders who have designated trading can receive their cash dividends on the payment date at their designated securities firms [2] - For shareholders who have not designated trading, the dividends will be held by China Securities Depository and Clearing Corporation Limited until they complete the designated trading [2] Taxation Information - For individual shareholders holding unrestricted shares, the actual cash dividend after tax is RMB 0.198 per share, depending on the holding period [3][4] - The tax rates for dividends vary based on the holding period: 20% for holdings of 1 month or less, 10% for holdings between 1 month and 1 year, and no tax for holdings over 1 year [3] - For foreign institutional investors, a 10% withholding tax applies, resulting in an actual cash dividend of RMB 0.198 per share [4][5]